Long Term Effect of Oxaliplatin Treatment in Cancer Survivors
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Multicentric Randomised Trial for Resectable Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Radiochemotherapy in Elderly Patients With Oesophagus Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
- Status
- COMPLETED
- Phase
- N/A
Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2